Ileostomy after intestinal transplantation: the first in depth report on techniques, complications, and outcomes.
Temporary ileostomy during intestinal transplantation (ITx) is the standard technique for allograft monitoring. A detailed analysis of the ITx ileostomy has never been reported. A retrospective review of a single-center ITx database was performed. The analysis was divided into ileostomy formation and takedown episodes. 135 grafts underwent ileostomy formation and 79 underwent ileostomy takedown. Median age at ITx was 7.7 yrs and weight was 23 kg. Allograft types were intestine (22%), liver/intestine (55%), multivisceral (16%), modified multivisceral (7%). 64% had 1-stage ITx whereas 36% required 2-staged ITx. Final ileostomy types were end (20%), loop (10%), distal blow-hole (59%) and proximal blow-hole (11%).Ileostomy formation: 31 grafts had complications (23%) including prolapse (26%), ischemia (16%), parastomal hernia (19%). 12 required surgical revision. There were no significant differences in graft type, ileostomy type, survival and ileostomy takedown rate between grafts with and without complications. Colon inclusive grafts had higher complication rates (p = 0.002).Ileostomy takedown: Ileostomy takedown occurred at a median of 422 days post-ITx. 25 complications occurred after 22 takedowns (28%) including SBO (27%) and abscess (18%). 15 grafts required surgical correction. Recipients with complications had longer hospital stay (17 vs. 9 days, p = 0.001) than those without complications. Graft type, ileostomy type and survival were not different. The first of its kind analysis of the surgical ileostomy after ITx reveals that most recipients can undergo successful ileostomy formation/takedown, complication rates are significant but within an acceptable range, and that complications do not affect survival. This study demonstrates that the routine use of transplant ostomies remains an acceptable practice after intestinal transplantation. However true analysis of risk and benefit will require a randomized, control trial.